Evaluation of susceptibility to antifungal agents of fungal strains isolated from pregnant women with diabetes and healthy pregnant women;Ocena wrażliwości na wybrane leki przeciwgrzybicze szczepów grzybów wyizolowanych od kobiet ciężarnych z cukrzycą oraz zdrowych

Ginekologia Polska

Volumn 80, Issue 4, 2009, Pages 274-279

  Dorota, Nowakowska ^a   Zuzanna, Gaj ^b   Wojciech, Sobala ^c   Jan, Wilczyński ^d  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c UM w odzi   (Poland)

^d Zak ed Zagroz e Fizycznych   (Poland)

Author keywords

Antifungal agents; Diabetes mellitus; Fungal infections; Pregnancy; Susceptibility

Indexed keywords

ANTIFUNGAL AGENT; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; MICONAZOLE; NATAMYCIN; NYSTATIN; TIOCONAZOLE;

ADULT; ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA; CLASSIFICATION; COMPARATIVE STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLAND; PREGNANCY; PREGNANCY COMPLICATION; REFERENCE VALUE;

ADULT; ANTIFUNGAL AGENTS; CANDIDA; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, FUNGAL; FEMALE; HUMANS; IMIDAZOLES; ITRACONAZOLE; MICONAZOLE; MICROBIAL SENSITIVITY TESTS; NATAMYCIN; NYSTATIN; POLAND; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REFERENCE VALUES; YOUNG ADULT;

EID: 67649802301     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Hospenthal D, Murray C, Rinaldi M. The role of antifungal susceptibility testing in the therapy of candidiasis. Diagn Microbiol Infect Dis. 2004, 48, 153-160.
2. Nowakowska D, Kurnatowska A, Stray-Pedersen B, [et al.]. Species distribution and influence of glycemic control on fungal infections in pregnant women with diabetes. J Infect. 2004, 48, 339-346.
3. Bates S. Vaginal discharge. Curr Opin Obstet Gynecol. 2003, 13, 218-223.
4. Ferrer J. Vaginal candidosis: epidemiological and etiological factors. Int J Gynaecol Obstet. 2000, 71, Suppl 1, S21-S27.
5. Remington J, Klein J. Infectious diseases of the fetus and newborn infant. Philadelphia: W.B. Saunders Company, 2001, 1371-1418.
6. Sanglard D, Odds F. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis. 2002, 2, 73-85.
7. Ciok-Pater E, BiaIucha A, Szabelska M, [i wsp.]. Mechanizmy opornoŚci drż dży na stosowane leki przeciwgrzybicze. Mikol Lek. 2008, 15, 49-53.
8. Zalecenia ZespoIu Ekspertów do Spraw Wczesnego Rozpoznawania Cukrzycy w Ciàży. Ginekol Pol. 1995, 66, 137.
9. European IDDM Policy Group. Consensus Guidelines for the Management Insulin Dependent Diabetes. Medicom Europe BV, Bessum, 1993.
10. Nowakowska D, Wilczyn_ski J, Kurnatowska A. Ocena wpIywu ste{ogonek}"enia glukozy we krwi na cź stoŚç wyste{ogonek}powania zara"eF grzybami pochwy, jamy ustnej i odbytu u kobiet cí "arnych z cukrzycà. Diabetol Pol. 2002, 9, 175-180.
11. Chong P, Abdul Hadi S, Lee Y, [et al.]. Genotyping and drug resistance profile of Candida spp. in recurrent and one-off vaginitis, and high association of non-albicans species with non-pregnant status. Infect Genet Evol. 2007, 7, 449-456.
12. Sobel J. Candidal vulvovaginitis. Clin Obstet Gynecol. 1993, 36, 153-165.
13. Hay P, Czeizel A. Asymptomatic Trichomonas and Candida colonization and pregnan- cy outcome. Best Pract Res Clin Obstet Gynaecol. 2007, 21, 403-409.
14. Torgerson R, Marnach M, Bruce A, [et al.]. Oral and vulvar changes in pregnancy. Clin Dermatol. 2006, 24, 122-132.
15. Nowakowska D, Gaj Z, Nowakowska-GIàb A, [i wsp.]. Cźe{ogonek}stośç wyste{ogonek}powania zarażeń grzybami u kobiet cí żarnych i niecíżarnych z cukrzycà i bez cukrzycy. Ginekol Pol. 2008, 80, 207-212.
16. Nowakowska D, Kurnatowska A, WilczyFski J. Multifocal fungal infections in pregnant women. Wiad Parazytol. 2001, 47, Suppl 1, 119-124.
17. Nowakowska D, Kurnatowska A, Stray-Pedersen B, [et al.]. Prevalence of fungi in the vagina, rectum and oral cavity in pregnant diabetic women: relation to gestational age and symptoms. Acta Obstet Gynecol Scand. 2004, 83, 251-256.
18. Trama J, Adelson M, Raphaelli I, [et al.]. Detection of Candida species in vaginal sam- ples in a clinical laboratory setting. Infect Dis Obstet Gynecol. 2005, 13, 63-67.
19. Cotch M, Hillier S, Gibbs R, [et al.]. Vaginal Infections and Prematurity Study Group. Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Am J Obstet Gynecol. 1998, 178, 374-380.
20. Hollmer C, Essmann M, Ault K, [et al.] Adherence and blocking of Candida albicans to cultured vaginal epithelial cells: treatments to decrease adherence. Infect Dis Obstet Gynecol. 2006, 2006, 98218.
21. Hryncewicz-Gwóźdź, A, Plomer-Niezgoda E, Baran E. TrudnoŚci lecznicze grzybicy u chorych na cukrzyce. Mikol Lek. 2006, 13, 315-317.
22. Goswami R, Dadhwal V, Tejaswi S, [et al.]. Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status. J Infect. 2000, 41, 162-166.
23. Malazy O, Shariat M, Heshmat R, [et al.]. Vulvovaginal candidiasis and its related fac- tors in diabetic women. Taiwan J Obstet Gynecol. 2007, 46, 399-404.
24. Manfredi M, McCullough M, Polonelli L, [et al.]. In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. Oral Microbiol Immunol. 2006, 21, 177-182.
25. Kuriyama T, Williams D, Bagg J, [et al.]. In vitro susceptibility of oral Candida to seven antifungal agents. Oral Microbiol Immunol. 2005, 20, 349-353.
26. Ļukaszuk C, Krajewska-KuIak E, Niczyporuk W, [i wsp.]. WrażliwoŚç na chemioter-apeutyki przeciwgrzybicze szczepów grzybów drż dżopodobnych izolowanych od pacjentów z chorobà nowotworowà. Onkol Pol. 1999, 4, 1-4.
27. Fryberg M, Oehlschlager A, Unrau A. Sterol biosynthesis in antibiotic-resistant yeast: nystatin. Arch Biochem Biophys. 1974, 160, 83-89.
28. Sojakova M, Liptajova D, Borovsky M, [et al.]. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia. Mycopathologia. 2004, 157, 163-169.
29. Wirsching S, Michel S, Köhler G, [et al.]. Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor. J Bacteriol. 2000, 182, 400-404.